In This Section      
Print This Page

Fisher Center Discovery Program

To develop excellence in clinical research regarding environmental infectious pathogens, the Center has created the Fisher Center Discovery Program (FCDP).  Goals of the FCDP include:

  • Funding of grants for clinical research related to environmental infectious diseases
  • Provision of resources for studies that lack traditional funding mechanisms
  • Promotion of cross-disciplinary collaborative research
  • Provision of mentoring opportunities for early career investigators

We award a maximum of $50,000 to individual researchers during a single annual grant cycle.  Notifications about the grants opportunity are distributed by email via individual schools of the Johns Hopkins University and pertinent faculty list serves.  All full-time faculty members of the Johns Hopkins University, especially junior faculty, are encouraged to apply. For questions concerning the grants program, please email or call 443-287-4840.

2018 Fisher Center Discovery Program Grant Cycle

The 2018 application space is now open.  Click on the name of the document for a hyperlink to that document.

DocumentDescriptionSubmission Deadline
Full ApplicationPDF fillable formSeptember 18, 2017
Application GuidelinesPDF read-only document 
Frequently Asked QuestionsPDF read-only document 
Letter of Intent FormPDF fillable formAugust 21, 2017
Budget TemplateExcel documentSeptember 18, 2017




Submit the Letter of Intent, application, and supporting documents via email,

Questions? Contact or 443-287-4840.


Prior Awards: Project TitleAward YearPrincipal Investigator, Johns Hopkins University
Development and Clinical Evaluation of Laboratory Methods to Identify Reduced Antiseptic Susceptibility in Organisms Causing Healthcare Associated Infections2013Aaron Milstone, M.D., M.H.S
Detection of Unrecognized Tick-borne Febrile illness in the Upper Midwest and Northeast United States2013Megan Reller, M.D., M.P.H.
Clostridium difficile: Impact of colonization versus transmission on development of infection2013Trish Perl, M.D.
Does Disruption of Host Microbiota Modify Colorectal Cancer Risk?2013Cynthia Sears, M.D.
Evolutionary dynamics of multidrug-resistant Staphylococcus aureus (MDRSA), a zoonotic pathogen of clinical significance, among industrial food animal production workers2013Christopher Heaney, Ph.D.
An evidence-based screening approach to identify children at high risk for harboring multi-drug resistant Gram-negative organisms in the PICU2014Pranita Tamma, M.D., M.H.S.
Home Environmental Exposure to Staphylococcal Bacteria and Asthma Exacerbation2014Elizabeth Matsui, M.D., M.H.S.
Identifying Environmental Transmission Routes for Shigellosis in Rural Settings using Pulsed-field Gel Electrophoresis2014Christine George, Ph.D.
Immune Events in Human Lyme Disease2014Mark Soloski, Ph.D.
Characterization of β-lactam Resistance in Enterobacteriaceae Isolated from the Chesapeake Bay and Upper Watershed2014Nicole Parrish, Ph.D.
Host Genetic Susceptibility to Cryptosporidia Infection2014Priya Duggal, Ph.D., M.P.H
Diagnostics for latent histoplasmosis2015Kieren Marr, M.D.
The Home Environment: Infections among Patients Discharged Home with Venous Catheters2015Trish Perl, M.D.
Salivary diagnostics for pathogens of clinical significance in childhood environmental enteropathy2015Margaret Kosek, M.D.
Identifying molecular targets for preventing multidrug tolerance in Mycobacterium avium infection2016Petros Karakousis, M.D.
The role of nsP3 in neurovirulence of chikungunya virus2016Diane Griffin, M.D., Ph.D.
Molecular Epidemiology of Carbapenem Resistant Gram-Negative Organisms (CROs) at Johns Hopkins Hospital: Do Patients Infected with CROs Contaminate the Hospital Room Environment?2016Patricia Simner, Ph.D.
High-density poultry operations and associated infectious disease risks2016Brian Schwartz, M.D., M.S.
Building a baseline for assessing the human health impact of a landmark legislative intervention on antibiotic use in industrial poultry production2017Keeve Nachman, PhD
Identification of early detection biomarkers and candidate therapeutics for congenital Zika virus infection2017Sabra L. Klein, PhD
African BAOBAB (Babesia Observational Antibody) Study2017Evan Bloch, MD
Impact of Heterogeneous Resistance Mechanisms on Hospital Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE)2017Aaron Milstone, MD